Discovery of first-in-class nanomolar inhibitors of heptosyltransferase I reveals a new aminoglycoside target and potential alternative mechanism of action

2022 / Scientific reports

A clinically relevant inhibitor for Heptosyltransferase I (HepI) has been sought after for many years because of its critical role… Continue reading Discovery of first-in-class nanomolar inhibitors of heptosyltransferase I reveals a new aminoglycoside target and potential alternative mechanism of action

Carlos Morillo